MYLET JOHANNA (Senior Vice President, Finance) received a stock award from POSEIDA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/2/2023ACC: 0001209191-23-014908
Officer· Senior Vice President, Finance
Since Jul 2020
+213.73K
Net shares
Net buyer
$23.1K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
218.06K acquired · 4.32K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+92.77K
Price / share
—
Trade value
—
% of position
104.0%
3/1/2023
89.18K→181.95K
Common Stock
Direct
Shares
−4.32K
Price / share
$5.35
Trade value
$23.13K
% of position
2.4%
3/1/2023
181.95K→177.63K
Total
Net shares
+88.45K
Net value
-$23.13K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2023 | A · Award | +92.77K | — | — | 104.0% | 89.18K | 181.95K |
| Common Stock Direct | 3/1/2023 | F · Tax Withholding | −4.32K | $5.35 | $23.13K | 2.4% | 181.95K | 177.63K |
| Total | +88.45K | -$23.13K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
125.28K shares
Shares
+125.28K
Strike price
5.35
Held after
125.28K
Exercisable
—
3/1/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock125.28K shares | 3/1/2023 | A · Award | +125.28K | 5.35 | — | 125.28K |